106 related articles for article (PubMed ID: 34914903)
1. Identifying features of genome evolution to exploit cancer vulnerabilities.
Dandage R; Landry CR
Cell Syst; 2021 Dec; 12(12):1127-1130. PubMed ID: 34914903
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive prediction of robust synthetic lethality between paralog pairs in cancer cell lines.
De Kegel B; Quinn N; Thompson NA; Adams DJ; Ryan CJ
Cell Syst; 2021 Dec; 12(12):1144-1159.e6. PubMed ID: 34529928
[TBL] [Abstract][Full Text] [Related]
3. Predicting human genetic interactions from cancer genome evolution.
Lu X; Megchelenbrink W; Notebaart RA; Huynen MA
PLoS One; 2015; 10(5):e0125795. PubMed ID: 25933428
[TBL] [Abstract][Full Text] [Related]
4. Targeting synthetic lethal paralogs in cancer.
Ryan CJ; Mehta I; Kebabci N; Adams DJ
Trends Cancer; 2023 May; 9(5):397-409. PubMed ID: 36890003
[TBL] [Abstract][Full Text] [Related]
5. Predicting synthetic lethal interactions in human cancers using graph regularized self-representative matrix factorization.
Huang J; Wu M; Lu F; Ou-Yang L; Zhu Z
BMC Bioinformatics; 2019 Dec; 20(Suppl 19):657. PubMed ID: 31870274
[TBL] [Abstract][Full Text] [Related]
6. An in-silico approach to predict and exploit synthetic lethality in cancer metabolism.
Apaolaza I; San José-Eneriz E; Tobalina L; Miranda E; Garate L; Agirre X; Prósper F; Planes FJ
Nat Commun; 2017 Sep; 8(1):459. PubMed ID: 28878380
[TBL] [Abstract][Full Text] [Related]
7. Patterns of genome dynamics and cancer evolution.
Heng HH; Stevens JB; Lawrenson L; Liu G; Ye KJ; Bremer SW; Ye CJ
Cell Oncol; 2008; 30(6):513-4. PubMed ID: 18936532
[No Abstract] [Full Text] [Related]
8. Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer.
Srihari S; Singla J; Wong L; Ragan MA
Biol Direct; 2015 Oct; 10():57. PubMed ID: 26427375
[TBL] [Abstract][Full Text] [Related]
9. Computational Cancer Biology: An Evolutionary Perspective.
Beerenwinkel N; Greenman CD; Lagergren J
PLoS Comput Biol; 2016 Feb; 12(2):e1004717. PubMed ID: 26845763
[No Abstract] [Full Text] [Related]
10. Machine learning spots natural selection at work in human genome.
Maxmen A
Nature; 2018 Nov; 563(7730):167. PubMed ID: 30401843
[No Abstract] [Full Text] [Related]
11. Genome-wide cell-free DNA fragmentation in patients with cancer.
Cristiano S; Leal A; Phallen J; Fiksel J; Adleff V; Bruhm DC; Jensen SØ; Medina JE; Hruban C; White JR; Palsgrove DN; Niknafs N; Anagnostou V; Forde P; Naidoo J; Marrone K; Brahmer J; Woodward BD; Husain H; van Rooijen KL; Ørntoft MW; Madsen AH; van de Velde CJH; Verheij M; Cats A; Punt CJA; Vink GR; van Grieken NCT; Koopman M; Fijneman RJA; Johansen JS; Nielsen HJ; Meijer GA; Andersen CL; Scharpf RB; Velculescu VE
Nature; 2019 Jun; 570(7761):385-389. PubMed ID: 31142840
[TBL] [Abstract][Full Text] [Related]
12. Genome evolution predicts genetic interactions in protein complexes and reveals cancer drug targets.
Lu X; Kensche PR; Huynen MA; Notebaart RA
Nat Commun; 2013; 4():2124. PubMed ID: 23851603
[TBL] [Abstract][Full Text] [Related]
13. Evolution of the cancer genome.
Yates LR; Campbell PJ
Nat Rev Genet; 2012 Nov; 13(11):795-806. PubMed ID: 23044827
[TBL] [Abstract][Full Text] [Related]
14. Link synthetic lethality to drug sensitivity of cancer cells.
Wang R; Han Y; Zhao Z; Yang F; Chen T; Zhou W; Wang X; Qi L; Zhao W; Guo Z; Gu Y
Brief Bioinform; 2019 Jul; 20(4):1295-1307. PubMed ID: 29300844
[TBL] [Abstract][Full Text] [Related]
15. Identification of synthetic lethality based on a functional network by using machine learning algorithms.
Li J; Lu L; Zhang YH; Liu M; Chen L; Huang T; Cai YD
J Cell Biochem; 2019 Jan; 120(1):405-416. PubMed ID: 30125975
[TBL] [Abstract][Full Text] [Related]
16. A network-based approach to integrate nutrient microenvironment in the prediction of synthetic lethality in cancer metabolism.
Apaolaza I; San José-Enériz E; Valcarcel LV; Agirre X; Prosper F; Planes FJ
PLoS Comput Biol; 2022 Mar; 18(3):e1009395. PubMed ID: 35286311
[TBL] [Abstract][Full Text] [Related]
17. A lethal combination for cancer cells: synthetic lethality screenings for drug discovery.
Ferrari E; Lucca C; Foiani M
Eur J Cancer; 2010 Nov; 46(16):2889-95. PubMed ID: 20724143
[TBL] [Abstract][Full Text] [Related]
18. Pseudogenes and their composers: delving in the 'debris' of human genome.
Sen K; Ghosh TC
Brief Funct Genomics; 2013 Nov; 12(6):536-47. PubMed ID: 23900003
[TBL] [Abstract][Full Text] [Related]
19. Paralog buffering contributes to the variable essentiality of genes in cancer cell lines.
De Kegel B; Ryan CJ
PLoS Genet; 2019 Oct; 15(10):e1008466. PubMed ID: 31652272
[TBL] [Abstract][Full Text] [Related]
20. Identifying collateral and synthetic lethal vulnerabilities within the DNA-damage response.
Pinoli P; Srihari S; Wong L; Ceri S
BMC Bioinformatics; 2021 May; 22(1):250. PubMed ID: 33992077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
